Product Information
NATEGLINIDE 60 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1794 per EA under NDC 68382072116. Its NADAC has been published 499 times since Mar 15, 2017.
FDA first approved this application on Jul 6, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382072116
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NATEGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205248FDA Approved
7/6/2016
TE Code
AB
On Market Since
10/27/2016
Pharmacological Classes
Price Statistics
The NADAC for NATEGLINIDE 60 MG TABLET has been published 499 times since Mar 15, 2017, and over the history we have for it it has declined 72.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1794 per EA |
|---|---|
| All-time high | $0.6492 (Aug 16, 2017) |
| All-time low | $0.1645 (May 22, 2024) |
| 52-week high | $0.2008 |
| 52-week low | $0.1726 |
| Median price | $0.2962 |
| Average price | $0.3204 |
| Largest weekly change | +30.3% (May 19, 2021) |
| Weeks tracked | 499 |
| Tracking since | Mar 15, 2017 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nateglinide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Glinide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NATEGLINIDE 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NATEGLINIDE 60 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1794 per EA (NDC 68382072116), effective Sep 30, 2026.
How has the price of NATEGLINIDE 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for NATEGLINIDE 60 MG TABLET has declined 72.2%. It has been tracked across 499 weekly CMS publications since Mar 15, 2017.
What are the highest and lowest recorded NADAC prices for NATEGLINIDE 60 MG TABLET?
Since Mar 15, 2017, the NADAC for NATEGLINIDE 60 MG TABLET has ranged from a low of $0.1645 (May 22, 2024) to a high of $0.6492 (Aug 16, 2017), with a median of $0.2962 per EA.
Are there cheaper alternatives to NATEGLINIDE 60 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NATEGLINIDE 60 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NATEGLINIDE 60 MG TABLET?
NATEGLINIDE 60 MG TABLET (NDC 68382072116) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.